The role of IL-13 in established allergic airway disease

Journal of Immunology

Volumn 169, Issue 11, 2002, Pages 6482-6489

  Taube, Christian ^a   Duez, Catherine ^a   Cui, Zhi Hua ^a   Takeda, Katsuyuki ^a   Rha, Yeong Ho ^a   Park, Jung Won ^a   Balhorn, Annette ^a   Donaldson, Debra D ^b   Dakhama, Azzeddine ^a   Gelfand, Erwin W ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b PFIZER INC   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; UNCLASSIFIED DRUG; ALLERGEN; CYTOKINE; IL 13 RECEPTOR ALPHA2 FC FUSION PROTEIN, CANIS FAMILIARIS; IL-13 RECEPTOR ALPHA2-FC FUSION PROTEIN, CANIS FAMILIARIS; IMMUNOGLOBULIN; INTERLEUKIN RECEPTOR; OVALBUMIN;

AERATION AND OXYGENATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; LUNG COMPLIANCE; LUNG LAVAGE; LUNG RESISTANCE; MOUSE; MOUSE STRAIN; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; AIRWAY RESISTANCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DRUG ANTAGONISM; GOBLET CELL; HYPERPLASIA; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME;

AIRWAY RESISTANCE; ALLERGENS; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; FEMALE; GOBLET CELLS; HYPERPLASIA; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS; INFLAMMATION; INTERLEUKIN-13; LUNG COMPLIANCE; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTORS, INTERLEUKIN; RECOMBINANT FUSION PROTEINS; RESPIRATORY HYPERSENSITIVITY; TIME FACTORS;

EID: 0036884608     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.11.6482     Document Type: Article

References (44)

1. Busse, W. W., R. L. Coffman, E. W. Gelfand, A. B. Kay, and L. J. Rosenwasser. 1995. Mechanisms of persistent airway inflammation in asthma: a role for T cells and T-cell products. Am. J. Respir. Crit. Care Med. 152:388.
2. Cohn, L., J. S. Tepper, and K. Bottomly. 1998. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161:3813.
3. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587.
4. Grunig, G., M. Wamock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, and D. B. Corry. 1998. Requirement for IL- 13 independently of IL-4 in experimental asthma. Science 82:2261.
5. Mattes, J., M. Yang, A. Siqueira, K. Clark, J. MacKenzie, A. N. McKenzie, D. C. Webb, K. I. Matthaei, and P. S. Foster. 2001. IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J. Immunol. 167:1683.
6. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167:4668.
7. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258.
8. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779.
9. Zurawski, G., and J. E. de Vries. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
10. Lin, J. X., T. S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, et al. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331.
11. Andrew, D. P., M. S. Chang, J. McNinch, S. T. Wathen, M. Rihanek, J. Tseng, J. P. Spellberg, and C. G. Elias 3rd. 1998. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161:5027.
12. de Vries, J. E. 1998. The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin. Immunol. 102.165.
13. Li, L., Y. Xia, A. Nguyen, Y. H. Lai, L. Feng, T. R. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477.
14. Pope, S. M., E. B. Brandt, A. Mishra, S. P. Hogan, N. Zimmermann, K. I. Matthaei, P. S. Foster, and M. E. Rothenberg. 2001. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108:594.
15. Shim, J. J., K. Dabbagh, I. F. Ueki, T. Dao-Pick, P. R. Burgel, K. Takeyama, D. C. Tam, and J. A. Nadel. 2001. IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am. J. Physiol. 280: L134.
16. Bochner, B. S., D. A. Klunk, S. A. Sterbinsky, R. L. Coffman, and R. P. Schleimer. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:799.
17. Zuhdi Alimam, M., F. M. Piazza, D. M. Selby, N. Letwin, L. Huang, and M. C. Rose. 2000. Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am. J. Respir. Cell Mol. Biol. 22:253.
18. McKenzie, G. J., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A. N. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423.
19. Wills-Karp, M. 2001. IL-12/IL-13 axis in allergic asthma. J. Allergy Clin. Immunol. 107:9.
20. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109.
21. Coyle, A. J., G. Le Gros, C. Bertrand, S. Tsuyuki, C. H. Heusser, M. Kopf, and G. P. Anderson. 1995. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am. J. Respir. Cell Mol. Biol. 13:54.
22. Hogan, S. P., A. Mould, H. Kikutani, A. J. Ramsay, and P. S. Foster. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99:1329.
23. Henderson, W. R., Jr., E. Y. Chi, and C. R. Maliszewski. 2000. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J. Immunol. 164:1086.
24. Tomkinson, A., A. Kanehiro, N. Rabinovitch, A. Joetham, G. Cieslewicz, and E. W. Gelfand. 1999. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am. J. Respir. Crit. Care Med. 160:1283.
25. Tomkinson, A., C. Duez, G. Cieslewicz, J. C. Pratt, A. Joetham, M. C. Shanafelt, R. Gundel, and E. W. Gelfand. 2001. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway cosinophilia and airway hyperresponsiveness. J. Immunol. 166:5792.
26. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. L. Henderson, R. M. O'Haral, Jr., D. R. Beier, K. J. Turner, C. R. Wood, and M. Collins. 1998. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α 1. J. Immunol. 161:2317.
27. Cockcroft, D. W., R. E. Ruffin, J. Dolovich, and F. E. Hargreave. 1977. Allergen-induced increase in non-allergic bronchial reactivity. Clin. Allergy 7:503.
28. Durham, S. R. 1991. The significance of late responses in asthma. Clin. Exp. Allergy 21:3.
29. Cieslewicz, G., A. Tomkinson, A. Adler, C. Duez, J. Schwarze, K. Takeda, K. A. Larson. J. J. Lee, C. G. Irvin, and E. W. Gelfand. 1999. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J. Clin. Invest 104:301.
30. Kanehiro, A., T. Ikemura, M. J. Makela, M. Lahn, A. Joetham, A. Dakhama, and E. W. Gelfand. 2001. Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am. J. Respir. Crit. Care Med. 163:173.
31. Takeda, K., E. Hamelmann, A. Joetham, L. D. Shultz, G. L. Larsen, C. G. Irvin, and E. W. Gelland. 1997. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J. Exp. Med. 186:449.
32. Tomkinson, A., G. Cieslewicz, C. Duez, K. A. Larson, J. J. Lee, and E. W. Gelfand. 2001. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice. Am. J. Respir. Crit. Care Med. 163:721.
33. Kanehiro. A., K. Takeda, A. Joetham, A. Tomkinson, T. Ikemura, C. G. Irvin, and E. W. Gelfand. 2000. Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. Am. J. Respir. Crit. Care Med. 162:1132.
34. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8:885.
35. Ray, A., and L. Cohn. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin Invest. 104:985.
36. Cohn, L., R. J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737.
37. Coffman, R. L., S. Mocci, and A. O'Garra. 1999. The stability and reversibility of Th1 and Th2 populations. Curr. Top. Microbiol. Immunol. 238:1.
38. Yang, E. S., A. Joetham, K. Takeda, Z. H. Cui, C. Taube, J. Tocker, and E. W. Gelfand. 2002. Anti-IL-4 receptor mAb attenuates allergic airway hyperresponsiveness and inflammation in allergic mice. J. Allergy Clin. Immunol. 109: A168.
39. Bryan, S. A., B. J. O'Connor, S. Matti, M. J. Leckie, V. Kanabar, J. Khan, S. J. Warrington, L. Renzetti, A. Rames, J. A. Bock, et al. 2000. Effects of recombinant human interleukin- 12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356:2149.
40. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. F. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356:2144.
41. Crosby, J. R., G. Cieslewicz, M. Borchers, E. Hines, P. Carrigan. J. J. Lee, and N. A. Lee. 2002. Early phase bronchoconstriction in the mouse requires allergen-specific IgG. J. Immunol. 168:4050.
42. Martin, T. R., S. J. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary response to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64:2318.
43. Moy, M. L., and S. H. Loring. 1998. Compliance. Semin. Respir. Crit. Care Med. 19:349.
44. Woolcock, A. J., N. J. Vincent, and P. T. Macklem. 1969. Frequency dependence of compliance as a test for obstruction in the small airways. J. Clin. Invest. 48:1097.